ANTIPYRINE HALF-LIFE AND DRUG ELIMINATIONBRECKENRIDGE A.1980; CLIN. PHARMACOKINET; NLD; DA. 1980; VOL. 5; NO 3; PP. 201-203; BIBL. 2 P.Article

PLACENTAL PROTEIN 5: DISAPPEARANCE FROM THE CIRCULATION AFTER DELIVERYOBIEKWE BC; SOOBY J; SALEM HT et al.1982; EUR. J. OBSTET. GYNECOL. REPROD. BIOL.; ISSN 0301-2115; NLD; DA. 1982; VOL. 13; NO 1; PP. 1-5; BIBL. 12 REF.Article

THE HALF LIFE OF FACTOR XIII IN THE MANAGEMENT OF INHERITED DEFICIENCYFEAR JD; MILOSZEWSKI KJA; LOSOWSKY MS et al.1983; THROMBOSIS AND HAEMOSTASIS; ISSN 0340-6245; DEU; DA. 1983; VOL. 49; NO 2; PP. 102-105; BIBL. 19 REF.Article

INDIVIDUAL MESSENGER RNA HALF LIVES IN SACCHAROMYCES CEREVISIAE.KOCH M; FRIESEN JD.1979; MOLEC. GEN. GENET.; DEU; DA. 1979; VOL. 170; NO 2; PP. 129-135; BIBL. 19 REF.Article

THE HALF-LIFE OF AMITROPTYLINEROGERS HJ; MORRISON PJ; BRADBROOK ID et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 2; PP. 181-183; BIBL. 7 REF.Article

LE METABOLISME DES ALPHA MACROGLOBULINES DU LAPIN: ETUDE DE LA DEMI-VIE.VERSAVEL C; JOUSSET STEVENET B; LEBRETON DE VONNE T et al.1977; C.R. SOC. BIOL.; FR.; DA. 1977; VOL. 171; NO 1; PP. 245-247; ABS. ANGL.; BIBL. 10 REF.Article

DOPAMINE BETA -HYDROXYLASE: DETERMINATION OF HALF-LIFE AND APPEARANCE IN LYMPH FLUID AFTER IV INJECTION OF ¹²⁵I-DBH INTO RATSGEYER SJ; SCHANBERG SM.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 13; PP. 1087-1100; BIBL. 28 REF.Article

MEASUREMENTS OF HALF-LIFE OF RAT CARDIAC MYOSIN HEAVY CHAIN WITH LEUCYL-TRNA USED AS PRECURSOR POOL.MARTIN AF; RABINOWITZ M; BLOUGH R et al.1977; J. BIOL. CHEM.; U.S.A.; DA. 1977; VOL. 252; NO 10; PP. 3422-3429; BIBL. 44 REF.Article

STUDY ON THE BIOLOGICAL HALF-LIFE AND ORGAN-DISTRIBUTION OF TRITIATED LYSINE-VASOPRESSIN IN BRATTLEBORO RATSLACZI F; LASZLO FA; KERI G et al.1980; ACTA PHYSIOL. ACAD. SCI. HUNG.; ISSN 0001-6756; HUN; DA. 1980; VOL. 55; NO 2; PP. 129-133; ABS. RUS; BIBL. 15 REF.Article

FUNCTIONAL M RNA HALF LIVES IN E. COLIPEDERSEN S; REEH S; FRIESEN JD et al.1978; MOLEC. GEN. GENET.; DEU; DA. 1978; VOL. 166; NO 3; PP. 329-336; BIBL. 30 REF.Article

SOMATOSTATIN HALF-LIFE: A CASE REPORT IN ONE HEALTHY VOLUNTEER AND A THREE MONTH FOLLOW-UPBETHGE N; DIEL F; ROSICK M et al.1981; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1981; VOL. 13; NO 12; PP. 709-710; BIBL. 6 REF.Article

FURTHER OBSERVATIONS ON RELATIONSHIPS BETWEEN ANTIPYRINE HALF-LIFE-CLEARANCE AND VOLUME OF DISTRIBUTION: AN APPRAISAL OF ALTERNATIVE KINETIC PARAMETERS USED TO ASSESS THE ELIMINATION OF ANTIPYRINESULTATOS LG; DVORCHIK BH; VESELL ES et al.1980; CLIN. PHARMACOKINET; NLD; DA. 1980; VOL. 5; NO 3; PP. 263-273; BIBL. 2 P.Article

DIE WIRKUNGSGERECHTE ANWENDUNG VON ALLOPURINOL IN DER LANGZEITBEHANDLUNG = L'EMPLOI DE L'ALLOPURINOL A ACTION CALCULEE PENDANT LE TRAITEMENT PROLONGEFENNER H.1980; FORTSCHR. D. MED.; DEU; DA. 1980; VOL. 98; NO 10; PP. 373-376; BIBL. 10 REF.Article

EFFECT OF PLASMA PROTEIN AND TISSUE BINDING ON THE BIOLOGIC HALF-LIFE OF DRUGSGIBALDI M; LEVY G; MCNAMARA PJ et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 1; PP. 1-4; BIBL. 16 REF.Article

METABOLIC CLEARANCE AND PLASMA HOLF-DISAPPEARANCE TIME OF EXOGENOUS SOMATOSTATIN IN MANSHEPPARD M; SHAPIRO B; PIMSTONE B et al.1979; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1979; VOL. 48; NO 1; PP. 50-53; BIBL. 20 REF.Article

THE HALF-LIFE OF MRNA IN SACCHAROMYCES CEREVISIAE.LI LI CHIA; MCLAUGHLIN C.1979; MOLEC. GEN. GENET.; DEU; DA. 1979; VOL. 170; NO 2; PP. 137-144; BIBL. 20 REF.Article

ZUR EFFEKTIVEN HALBWERTZEIT BEI DER RADIOJODTHERAPIE DER SCHILDDRUESE. = TEMPS DE DEMI-VIE EFFICACE DANS LE TRAITEMENT PAR IODE RADIOACTIF DES AFFECTIONS THYROIDIENNESHLISCS R; HENNIG K.1977; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1977; VOL. 32; NO 49; PP. 2336-2339; ABS. RUSSE ANGL.; BIBL. 3 REF.Article

MEASUREMENT OF HALF-LIFE OF HUMAN PLASMA FIBRINOGEN.STEIN TP; LESKIW MJ; WALLACE HW et al.1978; AMER. J. PHYSIOL., ENDOCRINOL. METABOL. GASTROINTESTIN. PHYSIOL.; USA; DA. 1978; VOL. 3; NO 5; PP. 504-510; BIBL. 43 REF.Article

HALF LIFE OF INJECTED ¹²⁵I-INSULIN IN CONTROL AND OB/OB MICE.CRESTO JC; LAVINE RL; BUCHLY ML et al.1977; ACTA PHYSIOL. LATINO AMER.; ARGENT.; DA. 1977; VOL. 27; NO 1; PP. 11-19; BIBL. 22 REF.Article

The Operational Multiple Dosing Half-life : A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage FormsSAHIN, Selma; BENET, Leslie Z.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2869-2877, issn 0724-8741, 9 p.Article

PHARMACOKINETICS OF HYDROXYETHYL STARCH IN NORMAL SUBJECTSYACOBI A; STOLL RG; SUM CY et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 4; PP. 206-212; BIBL. 18 REF.Article

ACETAMINOPHEN KINETICS IN THE ELDERLYDIVOLL M; ABERNETHY DR; AMEER B et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 2; PP. 151-156; BIBL. 26 REF.Article

ENVIRONMENTAL FACTORS AFFECTING PARACETAMOL METABOLISM IN LONDON FACTORY AND OFFICE WORKERSMUCKLOW JC; FRASER HS; BULPITT CJ et al.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 10; NO 1; PP. 67-74; BIBL. 28 REF.Article

FATTY ACIDS BOUND TO SERUMALBUMIN DECREASE THE HALF-LIFE OF THROMBOXANE A₂LAGARDE M; VELARDO B; BLANC M et al.1980; PROSTAGLANDINS; ISSN 0090-6980; USA; DA. 1980; VOL. 20; NO 2; PP. 275-283; BIBL. 14 REF.Article

NEW COMPARTMENT- AND MODEL-INDEPENDENT METHOD FOR RAPID CALCULATION OF DRUG ABSORPTION RATESCHIOU WL.1980; J. PHARM. SCI.; USA; DA. 1980; VOL. 69; NO 1; PP. 57-62; BIBL. 36 REF.Article